Anticancer activity of palladium-based complexes against triple-negative breast cancer

被引：114
|
作者：
Vojtek, Martin [1 ]
Marques, Maria P. M. [2 ,3 ]
Ferreira, Isabel M. P. L. V. O. [4 ]
Mota-Filipe, Helder [5 ]
Diniz, Carmen [1 ]
机构：
[1] Univ Porto, Fac Pharm, Dept Drug Sci, LAQV,REQUIMTE,Lab Pharmacol, Porto, Portugal
[2] Univ Coimbra, Dept Chem, Unidade I&D Quim Fis Mol, Coimbra, Portugal
[3] Univ Coimbra, Dept Life Sci, Coimbra, Portugal
[4] Univ Porto, Fac Pharm, Dept Chem Sci, LAQV,REQUIMTE,Lab Bromatol & Hydrol, Porto, Portugal
[5] Univ Lisbon, Fac Pharm, iMed ULisboa, Lisbon, Portugal
来源：
DRUG DISCOVERY TODAY | 2019年 / 24卷 / 04期
关键词：
BENZOPHENONE IMINES SYNTHESIS; CELLS IN-VITRO; ANTITUMOR-ACTIVITY; SACCHARINATE COMPLEX; CYTOTOXIC ACTIVITY; DNA-BINDING; MOLECULAR-MECHANISMS; PD(II) COMPLEXES; MUTANT P53; APOPTOSIS;
D O I：
10.1016/j.drudis.2019.02.012
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Treatment of triple-negative breast carcinoma (TNBC) remains an unmet medical need with no targeted therapy available to date. Accounting for 10-30% of all human breast cancer tumors, this mammary carcinoma subtype has a particularly poor prognosis owing to its high metastatic potential, aggressive biology and limited pharmacological treatment options. Platinum chemotherapeutics are the mainstay therapy in patients with TNBC but their clinical use is limited by severe toxicity and acquired resistance. Palladium-based complexes are appealing alternative metal-based drugs because of significant similarities regarding structure and coordination chemistry with the platinum agents. This review summarizes the knowledge gathered so far on 121 Pd(II) complexes, emphasizing their anticancer activity and putative pharmacological targets toward TNBC.
引用
收藏
页码：1044 / 1058
页数：15
相关论文
共 50 条
  • [31] Applicability of Anticancer Drugs for the Triple-Negative Breast Cancer Based on Homologous Recombination Repair Deficiency
    Liao, Gaoming
    Yang, Yiran
    Xie, Aimin
    Jiang, Zedong
    Liao, Jianlong
    Yan, Min
    Zhou, Yao
    Zhu, Jiali
    Hu, Jing
    Zhang, Yunpeng
    Xiao, Yun
    Li, Xia
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [32] An ER-α36 monoclonal antibody exhibits anticancer activity in triple-negative breast cancer cells
    Lin, Qingcong
    Zhou, Junma
    Wang, Jing
    Wang, Zonghui
    Wang, Jun
    Chen, Feng
    Qian, Xueming
    Shang, Xiao
    Bao, Jun
    Wang, Zhaoyi
    Meng, Kun
    CANCER RESEARCH, 2015, 75
  • [33] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
  • [34] Molecular Mechanism by which Coumestrol Exerts its Anticancer Activity in Triple-Negative Inflammatory Breast Cancer
    Rodriguez-Martir, Keishla M.
    Colon-Ortiz, Ayeisha N.
    Fuxa-Rey, Veronica
    Negron-Figueroa, Dalissa
    Morales-Rivera, Carlos S.
    Carrasquillo-Dones, Emmanuel A.
    Peterson-Peguero, Esther A.
    FASEB JOURNAL, 2022, 36
  • [35] Molecular Pathways of Rosmarinic Acid Anticancer Activity in Triple-Negative Breast Cancer Cells: A Literature Review
    Konstantinou, Evangelia K.
    Panagiotopoulos, Athanasios A.
    Argyri, Konstantina
    Panoutsopoulos, George I.
    Dimitriou, Maria
    Gioxari, Aristea
    NUTRIENTS, 2024, 16 (01)
  • [36] Copper-assisted anticancer activity of hydroxycinnamic acid terpyridine conjugates on triple-negative breast cancer
    Roy, Anindya
    Khatun, Sajmina
    Dewale, Prashant Dattatraya
    Rengan, Aravind Kumar
    Chinta, Jugun Prakash
    DALTON TRANSACTIONS, 2024, 53 (46) : 18640 - 18652
  • [37] Evaluation of biomolecular interactions and in vitro cytotoxic activity of mononuclear and polymeric copper(II)-based complexes against triple-negative breast cancer cells
    Mantoo, Imtiyaz Ahmad
    Prasad, Chandra Prakash
    Yousuf, Imtiyaz
    NEW JOURNAL OF CHEMISTRY, 2025, 49 (08) : 3351 - 3364
  • [38] Activity of dasatinib with chemotherapy in triple-negative breast cancer cells
    Tryfonopoulos, D.
    O'Donovan, N.
    Corkery, B.
    Clynes, M.
    Crown, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] The Anticancer Effect of 2′-3′-dehydrosalannol on Triple-negative Breast Cancer Cells
    Boopalan, Thiyagarajan
    Arumugam, Arunkumar
    Damodaran, Chendl
    Rajkumar, Lakshmanaswamy
    ANTICANCER RESEARCH, 2012, 32 (07) : 2801 - 2806
  • [40] The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
    Adinew, Getinet M.
    Taka, Equar
    Mendonca, Patricia
    Messeha, Samia S.
    Soliman, Karam F. A.
    NUTRIENTS, 2021, 13 (04)
12345